Top 20 tourist places in india

Sun Pharmaceutical Industries Ltd.’s U.S. subsidiary has agreed to pay more than $400 million to settle charges that it conspired to fix prices of generic drugs, in a long-running investigation by the Department of Justice, antitrust division and civil division of U.S. The antitrust division, according to a statement on the website of Department of Justice, announced a deferred prose.